← back to search

Olga Buzovetsky

Rockefeller University · US
Area of research
Virology · Molecular Biology
Research interest
Research interests include Decitabine, Azacitidine, Myeloid leukemia, Hypomethylating agent, and SAMHD1.
h-index
citations
82
works
1
NIH funding
primary concept
email

Recent publications

Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML
Nature Communications 2019cited by 82position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Constanze Schneider · Broad Institute1 papers (2019–2019)Nerea Ferreirós · Goethe University Frankfurt1 papers (2019–2019)Wolfgang Hartmann · University Hospital Münster1 papers (2019–2019)Thomas Oellerich · Goethe University Frankfurt1 papers (2019–2019)Hanibal Bohnenberger · University Medical Center Hamburg-Eppendorf1 papers (2019–2019)Philipp Ströbel · University Hospital Heidelberg1 papers (2019–2019)Tamara Rothenburger · Goethe University Frankfurt1 papers (2019–2019)Federico Comoglio · Engene (Brazil)1 papers (2019–2019)Dominique Thomas · Goethe University Frankfurt1 papers (2019–2019)Lars Kaderali · Institute of Bioinformatics and Systems Biology1 papers (2019–2019)Eva Wardelmann · Media Working Group1 papers (2019–2019)Yong Xiong · Shandong University1 papers (2019–2019)Jindřich Činátl · Goethe University Frankfurt1 papers (2019–2019) · 1 papers (2019–2019)Christoph Schliemann · FH Münster1 papers (2019–2019)Martin Michaelis · University of Kent1 papers (2019–2019)Gerd Geißlinger · Goethe University Frankfurt1 papers (2019–2019)Oliver T. Keppler · Department of Virology1 papers (2019–2019)Linus Angenendt · University Hospital of Basel1 papers (2019–2019)Anne C. Wilke · Goethe University Frankfurt1 papers (2019–2019)